EX
eXoZymes, Inc.
EXOZ · NASDAQ
$6.14 -11.84% (-$0.83)
1M -11.65%
Market Cap $57.0M
P/E Ratio -
Div. Yield -
ROE 292.13%
Piotroski F-Score Weak
1/9Valuation
0 /100
Expensive P/B 15.60x
P/E N/A
P/FFO N/A
Growth
100 /100
Growing Book val. growth 35.27%
EPS growth N/A
FCF growth N/A
Profitability
-
N/A Gross margin N/A
FCF margin N/A
Net margin N/A
Quality
0 /100
Poor ROIC 155.79%
Asset turnover 0.00x
ROE 292.13%
Debt
100 /100
Low Debt/Equity 0.20x
Current ratio 3.81x
Int. coverage N/A
Stability
1 /100
Unstable Beta 3.15x
Profitable years 0
EPS volatility 80.15%
Bulios Scoring descrie calitatea și istoricul unei companii, nu randamentul viitor. Un scor ridicat nu este un semnal de cumpărare. Află mai multe
Întreabă StockBot despre EXOZ
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Michael Heltzen
Employees
32
Headquarters
Monrovia